Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Microsatellite Stable (MSS) Colorectal Cancer (CRC): early-phase trial registry
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Microsatellite Stable (MSS) Colorectal Cancer (CRC): 2 US clinical trials tracked, none currently recruiting.
Microsatellite Stable (MSS) Colorectal Cancer (CRC) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Adlai Nortye Biopharma Co., running 1 of these trials.
Enrollment posture brief
Registry condition microsatellite-stable-mss-colorectal-cancer-crc
OPEN 0 | RECR 0% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Microsatellite Stable (MSS) Colorectal Cancer (CRC) has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Microsatellite Stable (MSS) Colorectal Cancer (CRC) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Microsatellite Stable (MSS) Colorectal Cancer (CRC) is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
Adlai Nortye Biopharma Co.
NCT04432857
Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer
University of Colorado, Denver
NCT06784947
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Microsatellite Stable (MSS) Colorectal Cancer (CRC) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Microsatellite Stable (MSS) Colorectal Cancer (CRC) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Microsatellite Stable (MSS) Colorectal Cancer (CRC) page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Microsatellite Stable (MSS) Colorectal Cancer (CRC) trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Adlai Nortye Biopharma Co. sponsors the most Microsatellite Stable (MSS) Colorectal Cancer (CRC) trials on record, review their full trial history before evaluating a specific study. See Adlai Nortye Biopharma Co.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Microsatellite Stable (MSS) Colorectal Cancer (CRC) condition card totals 2 registered trials; most-linked intervention On-Treatment Biopsy; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.